This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Frazier Life Sciences, a decades-old biotech investor, is raising another heap o...
Novo Nordisk is known for making therapies for some of the world’s most prevalen...
Plus, news about Tris Pharma and ARS Pharmaceuticals: Merck KGaA’s lupus dru...
Luxa Biotechnology said Thursday that its stem cell therapy helped improve visio...
Merck KGaA flagged that it might get hit by President Donald Trump’s tariffs aga...
Denali Therapeutics’ ALS program showed no effect on an important neurodegenerat...
Trump's FDA pick Martin Makary goes before the Senate today, giving one of the f...
Ahead of Merck KGaA’s earnings announcement Thursday, investors were mostly look...
Novo Nordisk is considering investigating its GLP-1 therapies in the treatment o...
ITM Isotope Technologies Munich’s radiopharma candidate reduced neuroendocrine t...
A federal judge on Wednesday blocked the NIH from issuing a cap on indirect cost...
Novo Nordisk got the green light to join a lawsuit by compounders against the FD...
While reshoring pharma production to the US is not impossible, government offici...
Two days after announcing plans to shut down an FDA lab devoted to ensuring the ...
Novo Nordisk cut the price of its weight loss blockbuster Wegovy by nearly two-t...